Also of interest....Krakenhaus are sponsoring the trial(ph1) with
the support of Immutep/Merck/Pfizer.......I like that approach, it ensures us
a degree of control over Efti......Without checking I'm sure Prof Al-Batran has
been associated with Prima Biomed in the CVAC days, so he is indeed
an Immutep aligned researcher.....The Insight trial has indeed interested
the big players and Krakenhaus and AL-Batran seem more than happy
to accomodate them as shown by today's ann.....Looking forward to
see the DAQ reaction tonight.......One thinks it will be positive but I'm
not falling into the trap of guessing.....Good fun this though....
Merck, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.020(6.06%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.3¢ | 30.5¢ | $1.905M | 6.153M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 13147 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 101130 | 2 |
View Market Depth
| Last trade - 16.10pm 26/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
